YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3– TransCon CNP ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

Renaissance Technologies, founded by the late Jim Simons, cuts its Tesla and Nvidia stakes while raising its GameStop ...

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Dr. Dantonel brings over two decades of profound expertise in biological sciences, project management, and clinical research to his new role. He has extensive experience in academia, research, ...

Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

In appraisal of Kenvue’s visual identity, the logo for the independent new company ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma ...

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 4,32,084.24 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...